Skip to main content
Clinical Trials/NCT06498739
NCT06498739
Completed
Not Applicable

Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy. A Randomized Comparative Study

Cairo University1 site in 1 country52 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Erector spinae plane block(15 ml bupivacaine 0.5%)
Conditions
Erector Spinae Plane Block
Sponsor
Cairo University
Enrollment
52
Locations
1
Primary Endpoint
Total morphine consumption
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

Comparing the perioperative analgesic effect of two different volumes of local anesthetic solution in erector spinae plane block in patients undergoing modified radical mastectomy. A randomized comparative study.

Detailed Description

Breast cancer is the most common malignancy among females with incidence of about 2.1 million women each year. Modified Radical Mastectomy (MRM) is one of the main surgical treatments of breast cancer. Pain can be severe enough to cause long-term disabilities and interfere with sleep and performance of daily activities . Multiple regional techniques have been developed in recent years for postoperative analgesia of breast surgery inkling erector spinae plane block (ESPB) aiming to be effective and associated with less complications when compared to the gold standard techniques (thoracic epidural analgesia or paravertebral block). Ultrasound guided erector spinae plane block (ESPB) was described in 2016 as a novel regional anesthetic technique for acute and chronic thoracic pain, it has been used as a regional anesthetic technique for breast surgery based on case reports and case series. It is a paraspinal fascial plane block that involves injection of local anesthetic deep in the erector spinae muscle and superficial to the tips of the thoracic transverse processes. The site of injection is distant from the pleura, major blood vessels, and spinal cord.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
September 1, 2024
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yasmina Sayed

Assistant lecturer of anesthesiology and surgical ICU and pain management

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Age from 18 to 60 years.
  • Genders eligible for study: female sex.
  • American Society of Anesthesiologists (ASA) I-II.
  • Undergoing modified radical mastectomy.
  • Body mass index (BMI) from 18.5 to 30 kg.

Exclusion Criteria

  • Patient refusal.
  • Known allergy to local anesthetics .
  • Bleeding disorders; platelets count \<50,000 ,prothrombin concentration \< 60% or any coagulopathy disorder.
  • Use of any anti-coagulants .
  • Inability to provide informed consent.
  • Neurological disorders.
  • Patient with psychiatric disorders.

Arms & Interventions

Erector Spinae Plane block (high concentration-low volume)

Patients will preoperatively receive high concentration-low volume ultrasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% }, for each patient).

Intervention: Erector spinae plane block(15 ml bupivacaine 0.5%)

Erector Spinae Plane block (low concentration-high volume)

Patients will preoperatively receive low concentration-high volume ultrasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline}, for each patient.

Intervention: Erector spinae plane block (15 ml bupivacaine 0.5% and 15ml normal saline)

Outcomes

Primary Outcomes

Total morphine consumption

Time Frame: 24 hours postoperative

Rescue analgesia will be provided in the form of intravenous morphine 3 mg boluses if the patient indicates visual analogue scale ≥ 4. The total amount of morphine given in 24 hours will be recorded for the two groups. A maximum dose of 0.5 mg/kg/24hours of morphine is allowed. Visual Analogue Scale (VAS) (0 represents "no pain" while 10 represents "the worst pain imaginable").

Secondary Outcomes

  • Time 1st rescue analgesia(24 hours postoperative)
  • Pain score(24 hours postoperative)

Study Sites (1)

Loading locations...

Similar Trials